×
Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole: A Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole: A Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Adequacy of Treatment Received by Diagnosed and Undiagnosed Patients With Bipolar I and II Disorders PDF
$ 40.00
Adequacy of Treatment Received by Diagnosed and Undiagnosed Patients With Bipolar I and II Disorders PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression PDF
$ 40.00
A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid Depression PDF quantity
$ 40.00
×
Nocturnal Sleep Disturbances as a Predictor of Suicide Attempts Among Psychiatric Outpatients: A Clinical, Epidemiologic, Prospective Study PDF
$ 40.00
Nocturnal Sleep Disturbances as a Predictor of Suicide Attempts Among Psychiatric Outpatients: A Clinical, Epidemiologic, Prospective Study PDF quantity
$ 40.00
×
Paroxetine Treatment of Episodic Rages Associated With Tourette's Disorder PDF
$ 40.00
Paroxetine Treatment of Episodic Rages Associated With Tourette's Disorder PDF quantity
$ 40.00
×
Oxcarbazepine in the Treatment of Borderline Personality Disorder: A Pilot Study PDF
$ 40.00
Oxcarbazepine in the Treatment of Borderline Personality Disorder: A Pilot Study PDF quantity
$ 40.00
×
Quetiapine and Drug Interactions: Evidence From a Routine Therapeutic Drug Monitoring Service PDF
$ 40.00
Quetiapine and Drug Interactions: Evidence From a Routine Therapeutic Drug Monitoring Service PDF quantity
$ 40.00
×
Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic PDF
$ 40.00
Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart